Filter announcements
Loading...
Founded in June 1998, Quest Laboratories Limited produces a diverse range of pharmaceuticals, including antibiotics, antimalarials, anti-inflammatories, etc.
No content was provided to summarize. Please provide the company update text.
Quest Laboratories has re-opened its trading window. The company is discontinuing voluntary quarterly financial results, reverting to statutory half-yearly disclosures for SME-listed entities. Consequently, the Q1 results will not be announced, impacting regular investor updates.
Quest Laboratories has shifted its financial reporting from quarterly to half-yearly. This operational change aligns with SME regulations, aiming to streamline administrative processes.
Quest Laboratories' monthly sales were Rs. 8.18 Cr, a decline of 11.82% year-on-year. Year-to-date sales reached Rs. 35.88 Cr, up 29.51%. The monthly dip stems from facility upgrades and GST changes affecting order timing. Company will continue reporting monthly sales.
QUESTLAB received a cautionary email from NSE regarding a procedural delay in intimating an investor meet. NSE noted the lapse, urging the company to take corrective measures to ensure timely future disclosures and compliance.